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EDITORIAL
Genetic  Variations  and  Gastric  Cancer  Risk
Alterac¸ões  Genéticas  e  Risco  de  Cancro  Gástrico
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Gastric  cancer  used  to  be  the  leading  cause  of  cancer  deaths
in  the  world  until  the  1980  when  it  was  overtaken  by  lung
cancer.1 Nowadays,  stomach  cancer  is  the  second  leading
cause  of  cancer  death  in  both  sexes  worldwide.  In  spite
of  worldwide  global  decrease,  in  2020  (using  computing
models),  the  prevalence  of  gastric  cancer  is  expected  to  rise
in  Portugal,  for  both  sexes  (Globocan).  Most  patients  die  dur-
ing  the  ﬁrst  year  after  the  diagnosis,  even  if  submitted  to
costly  and  aggressive  therapy.2
Intestinal  type  is  more  frequently  observed  in  older
patients  and  represents  the  end  product  of  a  cascade  of
events  that  begin  with  multifocal  atrophic  gastritis  after
exposure  to  environmental  risk  factors  like  Helicobacter
pylori  (H.  pylori) infection.  This  is  usually  accompanied  by
intestinal  metaplasia  and  leads  to  cancer  via  dysplasia.3
This  lengthy  process,  commonly  known  as  Correa  Cascade,
is  dependent  on  continued  chronic  inﬂammation.4--6
Unlike  intestinal  gastric  cancer,  the  diffuse  type  typically
develops  following  chronic  inﬂammation  without  passing
through  the  intermediate  steps  of  glandular  atrophy  and
intestinal  metaplasia.  So  far,  H.  pylori  gastritis  is  the  only
universal  precursor  condition  for  this  subtype  of  gastric
cancer.7,8
Signiﬁcant  advances  toward  the  understanding  of  gastric
carcinogenesis  have  been  achieved  since  the  identiﬁca-
tion  of  H.  pylori  by  Marshall  and  Warren  in  1984,9 and  its
latter  classiﬁcation  as  a  class  I  carcinogen  by  the  Interna-
tional  Agency  for  Research  on  Cancer.  Colonization  is  usually
asymptomatic  and  tumor  progression  only  occurs  in  a  subsetDOI of original article: http://dx.doi.org/10.1016/j.jpge.
2015.04.001
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f  individuals  and  is  dependent  on  the  host  response  as  well
s  genetic  variation  of  the  bacteria.10
An  immensity  of  genes  and  genetic  variations  and  its
mplications  in  gastric  carcinogenesis  has  been  addressed
lthough  its  relevance  is  not  always  clear.  In  the  last  few
ears,  the  role  of  host  genetic  interleukin  polymorphisms  has
een  widely  studied  regarding  premalignant  lesions  and  as
iomarkers  for  genetic  susceptibility  in  gastric  cancer  devel-
pment.  The  best  characterized  by  population-association
tudies  are  those  respecting  the  inﬂammatory  response
o  H.  pylori  infection  and  the  damage-induced  inﬂamma-
ion  of  the  gastric  mucosa  leading  to  mucosal  atrophy  and
rogression  to  gastric  cancer,  mainly  IL-1, IL1  Receptor
ntagonist  (IL-1RN),  IL8IL10  and  TNF-. Genetic  polymor-
hisms  directly  inﬂuence  inter-individual  variation  in  the
agnitude  of  cytokine  response  and  this  clearly  contributes
o  an  individual’s  ultimate  clinical  outcome.  Early  studies  by
l-Omar  showed  an  association  of  gastric  cancer  risk  with  the
enotypes  carrying  IL-1-511T,  IL-1-31T and  IL-1RN*2/*2
ith  OR  of  2.5,  2.6  and  3.7  for  the  homozygotes.11 Studies  on
ortuguese  population  conﬁrmed  the  relevance  of  some  of
he  proinﬂammatory  polymorphisms  and  genetic  variations
f  H.  pylori.12--15 Following  results  were  inconsistent  because
f  variation  of  allele  frequencies  in  different  ethnic  groups,
umor  type  and  location,  H.  pylori  infection,  methodologies
nd  quality  of  studies.16,17
The  study  of  host  genetics  brought  a  better  understand-
ng  of  disease  pathogenesis  and  helped  in  conﬁrming  two
ey-points:  the  important  role  of  H.  pylori  infection  in  gas-
ric  carcinogenesis  and  the  role  of  chronic  inﬂammation  with
ts  long-term  deleterious  effects  on  gastric  physiology.  How-
ver,  the  heterogeneity  of  results  at  the  present  time  makes
t  difﬁcult  to  translate  them  into  recommendations  for  daily
linical  practice.
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In  this  issue  of  GE,  Carvalho  L  et  al  describes  the  asso-
iation  between  host  cytokines  polymorphisms  and  gastric
ancer  risk,  namely  IL-4  and  IL-6.18 It  concludes  that  spe-
iﬁc  IL-4  and  IL-6  polymorphisms  are  associated  with  GC
isk  either  the  Lauren’s  diffuse  type  and/or  the  intestinal
ype.  Some  limitations  could  be  pointed  such  as  the  low
umber  of  patients  and  controls  in  the  context  of  genetic
ssociation  studies,  the  representativeness  of  population
nd  the  accuracy  of  the  data.  Nevertheless,  new  insights
bout  the  role  of  IL-6  and  IL-4  expression  variants  and  gas-
ric  inﬂammation/cancer  risk  in  a  Portuguese  population  are
resented.
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